President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

After posting a double beat for Q2 2025, J&J (NYSE:JNJ), the pharma sector’s bellwether for the earnings season, added ~6% on ...

At a Cabinet meeting earlier this month, Trump said that he expected pharmaceutical tariffs to grow as high as 200% after ...

The measure raises taxes on the endowments of the nation's largest universities but not those of private charitable ...

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...

President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.

Trump’s threat to slap a 200% tariff on pharmaceutical imports, made offhandedly at a cabinet meeting, has sparked a selloff in some drug stocks, but analysts say the number may be more political ...

As trade tensions escalate under Donald Trump, India finds itself in the crosshairs once again. Donald Trump's proposed ...

Trump called for pharmaceutical tariffs again, noting he’d be applying 200% tariffs on imported drug products “very soon.” ...